Antiviral activity of green tea catechins against feline calicivirus as a surrogate for norovirus

Food Science and Biotechnology

Volumn 22, Issue 2, 2013, Pages 593-598

  Oh, Eun Gyoung ^a   Kim, Kyoung Lan ^b   Shin, Soon Bum ^a   Son, Kwang Tae ^a   Lee, Hee Jung ^a   Kim, Tae Hoon ^c   Kim, Young Mog ^b   Cho, Eun Ji ^d   Kim, Do Kyun ^d   Lee, Eun Woo ^d   Lee, Myung Suk ^b   Shin, Il Shik ^e   Kim, Ji Hoe ^a  

^a National Fisheries Research and Development Institute (NFRDI)   (South Korea)

^b Pukyong National University   (South Korea)

^c Daegu Haany University   (South Korea)

^d Dong Eui University   (South Korea)

^e Gangneung Wonju National University   (South Korea)

Author keywords

antiviral activity; Camellia sinensis; catechin; feline calicivirus; norovirus

Indexed keywords

CHLORINE COMPOUNDS; HEXANE; ORGANIC SOLVENTS; PHENOLS; PLANT EXTRACTS; TEA; VITAMINS;

ANTIVIRAL ACTIVITIES; CAMELLIA SINENSIS; CATECHIN; FELINE CALICIVIRUS; NOROVIRUS;

FLAVONOIDS;

CAMELLIA SINENSIS; FELINE CALICIVIRUS; NOROVIRUS; VESIVIRUS;

EID: 84876841755     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-013-0119-4     Document Type: Article

References (24)

1. Leuenberger S, Widdowson MA, Feilchenfeldt J, Egger R, Streuli RA. Norovirus outbreak in a district general hospital-new strain identified. Swiss Med. Wkly. 27: 57-81 (2007).
2. Cheesbrough JS, Barkess-Jones L, Brown DW. Possible prolonged environmental survival of small round structured viruses. J. Hosp. Infect. 35: 325-326 (1997).
3. Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL. Norwalk virus: How infectious is it? J. Med. Virol. 80: 1468-1476 (2008).
4. Hall AJ, Eisenbart VG, Etingüe AL, Gould LH, Lopman BA, Parashar UD. Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg. Infect. Dis. 18: 1566-1573 (2012).
5. Caul EO. Small round structured viruses: Airborne transmission and hospital control. Lancet 343: 1240-1242 (1994).
6. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. New Engl. J. Med. 18: 1776-1785 (2009).
7. Fankhauser RL, Monroe SS, Noel JS, Humphrey CD, Bresee JS, Parashar UD, Ando T, Glass RI. Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J. Infect. Dis. 186: 1-7 (2002).
8. Monroe SS. Control and prevention of viral gastroenteritis. Emerg. Infect. Dis. 17: 1347-1348 (2011).
9. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85: 79-87 (2004).
10. Bidawid S, Malik N, Adegbunrin O, Sattar SA, Farber JM. A feline kidney cell line-based plaque assay for feline calicivirus, a surrogate for Norwalk virus. J. Virol. Methods 107: 163-167 (2003).
11. Schäfer H, Wink M. Medicinally important secondary metabolites in recombinant microorganisms or plants: Progress in alkaloid biosynthesis. Biotechnol. J. 4: 1684-1703 (2009).
12. Marinangeli CP, Jones PJ. Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome. Ann. Med. 42: 317-333 (2010).
13. Gertsch J. Botanical drugs, synergy, and network pharmacology: Forth and back to intelligent mixtures. Planta Med. 77: 1086-1098 (2011).
14. Braicu C, Pilecki V, Balacescu O, Irimie A, Neagoe IB. The relationships between biological activities and structure of flavan-3-ols. Int. J. Mol. Sci. 12: 9342-9353 (2011).
15. Kampf G, Grotheer D, Steinmann J. Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus. J. Hosp. Infect. 60: 144-149 (2005).
16. Kim KL, Lee DS, Park MS, Eom SH, Lim KS, Kim JS, Lee DH, Kang CK, Kim YM, Lee MS. Antiviral activity of seaweed extracts against feline calicivirus. Fish. Aqua. Sci. 13: 96-101 (2010).
17. Bellamy K. A review of the test methods used to establish virucidal activity. J. Hosp. Infect. 30: S389-S396 (1995).
18. Umegaki K, Sugisawa A, Yamada K, Higuchi M. Analytical method of measuring tea catechins in human plasma by solid-phase extraction and HPLC with electrochemical detection. J. Nutr. Sci. Vitaminol. 47: 402-408 (2010).
19. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidem. Biomar. 10: 53-58 (2001).
20. Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279: 30994-31001 (2004).
21. Rusak G, Komes D, Likic S, Horzic D, Kovac M. Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. Food Chem. 110: 852-858 (2008).
22. Nance CL, Siwak EB, Shearer WT. Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy. J. Allergy Clin. Immun. 123: 459-465 (2009).
23. Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH, Dou QP. Recent advances on tea polyphenols. Front. Biosci. 4: 111-131 (2012).
24. Yin Z, Henry EC, Gasiewicz TA. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 48: 336-345 (2009).